Sarah Sampsel

Ms. Sampsel is a Vice President at Discern Health. Prior to joining Discern, Ms. Sampsel was a Senior Director in Quality Measurement at the National Quality Forum (NQF). As such, she directed consensus development projects focused on the endorsement of performance measures and Measures Application Partnership (MAP) processes resulting in recommendations of measures for use in federal programs. Areas of specialization included: patient reported outcome performance measures (PRO-PMs), person- and family-centered care, transitions of care and renal measurement. Additionally, she provided oversight for the Post-Acute Care (PAC) and Long-Term Care (LTC) Workgroup for the Measures Application Partnership and a Moore Foundation funded project focused on the certification of patient decision aids. Ms. Sampsel has over 20 years’ experience in a variety of health care settings, including health care delivery systems and health insurance plans (CO-OP, Exchange, Medicare Advantage, Medicaid and Commercial, Behavioral Health). She has extensive knowledge of quality measurement, accreditation, compliance, and stakeholder engagement.

Prior to joining NQF, Ms. Sampsel established a consulting practice providing services to health plans, federal contractors and non-profit organizations related to quality measurement and accreditation. She has been employed by health plans: Anthem, Magellan, New Mexico Health Connections, and in these roles has lead teams focused on quality measure improvement and public health policy.

In addition, Ms. Sampsel has held various performance measurement-focused positions at the National Committee for Quality Assurance (NCQA). In her roles, she was responsible for developing, implementing and maintaining HEDIS measures as well as managing research studies to support NCQA’s measure development activities.

Ms. Sampsel received her bachelor’s degree in health care administration from Bowling Green State University and her Master in Public Health from The Ohio State University. She serves on the board of The Ohio State University College of Public Health Alumni. Ms. Sampsel has a special interest in chronic kidney disease and End-Stage Renal Disease (ESRD) as a living kidney donor.


Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

September 2018 Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the mo...
Learn More



Contact Us


Guy D’Andrea Speaks About Innovative Payment Models

September 2018 Click here to view the VIDEO...
Learn More